Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
10.48
+0.26 (2.54%)
Aug 19, 2026, 4:00 PM EDT - Market closed

Orthofix Medical Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Orthofix Medical stock has a consensus rating of "Buy" and an average price target of $13. The average 1-year stock price forecast is 24.05% higher than the current stock price, while the lowest is $12 (+14.50%) and the highest is $14 (+33.59%).

Price Target: $13 (+24.05%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$12$13$13$14
Change+14.50%+24.05%+24.05%+33.59%

Analyst Ratings

The average analyst rating for Orthofix Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy222222
Buy111111
Hold222222
Sell000000
Strong Sell000000
Total555555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$13
BuyMaintains$13+24.05%Aug 10, 2026
Barrington
Barrington
Buy
Maintains
$17$14
BuyMaintains$17$14+33.59%Aug 6, 2026
TD Cowen
TD Cowen
Hold
Maintains
$12
HoldMaintains$12+14.50%Aug 6, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$15$13
BuyMaintains$15$13+24.05%Aug 5, 2026

Financial Forecast

Revenue This Year
850.96M
from 822.31M
Increased by 3.48%
Revenue Next Year
871.91M
from 850.96M
Increased by 2.46%
EPS This Year
0.41
from 0.49
Decreased by -15.88%
EPS Next Year
0.37
from 0.41
Decreased by -9.76%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
464.48M460.71M746.64M799.49M822.31M850.96M
Revenue Growth
14.25%-0.81%62.06%7.08%2.85%3.48%
Gross Profit
349.57M337.17M522.32M558.07M576.88M609.93M
Gross Margin
75.26%73.18%69.96%69.80%70.15%71.68%
Operating Income
-134.00K-30.47M-105.77M-65.53M-57.61M-23.83M
Net Income
-38.38M-19.75M-151.40M-126.00M-92.19M-36.35M
EPS
----0.490.41
EPS Growth
----5,041.35%-15.88%
Forward PE
35.2621.8822.0322.0326.7025.56
Free Cash Flow
20.23M-36.18M-140.87M55.42M27.32M-33.44M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High852.4M
Avg851.0M
Low849.6M

Revenue Growth

Revenue Growth202620272028
High
3.7%
Avg
3.5%
Low
3.3%

EPS Forecast

EPS202620272028
High0.41
Avg0.41
Low0.41

EPS Growth

EPS Growth202620272028
High
-15.9%
Avg
-15.9%
Low
-15.9%